GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
Formosa Pharmaceuticals signs licensing deal with Arrotex for APP13007 in Australia and New Zealand
Merck and Mayo Clinic launch AI-driven drug discovery collaboration
STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)
Hoth Therapeutics granted US patent for novel exon-skipping therapy targeting allergic diseases
DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval
Devonian reports gene expression data showing Thykamine's molecular effects in MASH model
Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris